Knowledge of the immunological events necessary to control hepatitis B virus (HBV) infection has accelerated in recent years, but their translation towards therapeutic strategies able to achieve a durable HBV suppression has been challenging. The scenario of how HBV deals with the host immunity is presented and used to discuss how the immune response can be harnessed to potentially achieve infection control
Hepatitis B virus (HBV) infections are among the major health problems and leading causes of cirrhos...
HBV is a hepatotropic and non-cytopathic virus that causes more than one million deaths annually fro...
During hepatitis B virus (HBV) infection, the presence of HBV-specific antibody producing B cells an...
Knowledge of the immunological events necessary to control hepatitis B virus (HBV) infection has acc...
Abstract Hepatitis B virus (HBV) infection has a low rate of chronicity compared to HC...
Hepatitis B virus (HBV) infection acquired in adult life is generally self-limited while chronic per...
textabstractClinical events and the host immune response during hepatitis B virus (HBV) infection ar...
Fewer than 1% of chronic hepatitis B virus infections per year are cured with antiviral treatment. T...
Hepatitis B virus (HBV) infection is still one of the most dangerous viral illnesses. HBV infects ar...
Human hepatitis B virus (HBV) infects the liver of humans or humanoid primates. In humans, HBV infec...
Chronic viral hepatitis infections are a major public health concern, with an estimated 290 million ...
Chronic hepatitis B infection remains a major global health problem despite the existence of an effe...
[[abstract]]Chronic hepatitis B virus (HBV) infection is a global public health issue. There are >25...
The successful control of HBV infection requires an efficient expansion of distinct elements of the ...
Hepatitis B virus (HBV) is a major cause of chronic liver inflammation worldwide. Recent knowledge o...
Hepatitis B virus (HBV) infections are among the major health problems and leading causes of cirrhos...
HBV is a hepatotropic and non-cytopathic virus that causes more than one million deaths annually fro...
During hepatitis B virus (HBV) infection, the presence of HBV-specific antibody producing B cells an...
Knowledge of the immunological events necessary to control hepatitis B virus (HBV) infection has acc...
Abstract Hepatitis B virus (HBV) infection has a low rate of chronicity compared to HC...
Hepatitis B virus (HBV) infection acquired in adult life is generally self-limited while chronic per...
textabstractClinical events and the host immune response during hepatitis B virus (HBV) infection ar...
Fewer than 1% of chronic hepatitis B virus infections per year are cured with antiviral treatment. T...
Hepatitis B virus (HBV) infection is still one of the most dangerous viral illnesses. HBV infects ar...
Human hepatitis B virus (HBV) infects the liver of humans or humanoid primates. In humans, HBV infec...
Chronic viral hepatitis infections are a major public health concern, with an estimated 290 million ...
Chronic hepatitis B infection remains a major global health problem despite the existence of an effe...
[[abstract]]Chronic hepatitis B virus (HBV) infection is a global public health issue. There are >25...
The successful control of HBV infection requires an efficient expansion of distinct elements of the ...
Hepatitis B virus (HBV) is a major cause of chronic liver inflammation worldwide. Recent knowledge o...
Hepatitis B virus (HBV) infections are among the major health problems and leading causes of cirrhos...
HBV is a hepatotropic and non-cytopathic virus that causes more than one million deaths annually fro...
During hepatitis B virus (HBV) infection, the presence of HBV-specific antibody producing B cells an...